lower leg fracture
Conditions
Interventions
Ropivacaine "pan" sign anterior sciatic nerve block group(group L):0.5%ropivacaine20ml
Bupivacaine liposome "pan" sign anterior sciatic nerve block group(group B):bupivacaine liposome 20ml(266mg)
Sponsors
Lu'an Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients with ASA grade I-III elective open reduction and internal fixation of lower leg fractures; 2. Age 18-65 years old; 3. BMI: 18-30kg/m2;4. Voluntarily signed informed consent and willing to comply with the requirements of the trial protocol
Exclusion criteria
Exclusion criteria: 1.Refusal to participate;2.History of allergy or specific reaction to amide local anesthetics ;3.BMI> 30 kg/m2 ;4.Severe cardiac, pulmonary and renal insufficiency, combined with a variety of chronic diseases unable to tolerate surgical anesthesia and psychiatric diseases;5.Those with a history of alcoholism, opioid allergy, or drug abuse ;6.Patients with uncontrolled hypertension and diabetes;7.Pregnant or lactating women;8.Those with a history of neurological diseases or inability to communicate normally
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale (VAS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative sufentanil dosage;Additional dose of sufentanil;Pressing times of patient-controlled analgesia;lower limb motor nerve block scale (modified Bromage);Postoperative complication; | — |
Countries
China
Contacts
Public ContactLi Zhan
Lu'an Hospital of Anhui Medical University
Outcome results
None listed